Companies: 10,795·Total market cap: $144.5T
Repligen Corporation

Repligen Corporation

RGENNASDAQHealthcare● Active
$122.31
$-4.24(-3.35%)
Market Cap$6.9B
P/E Ratio
52W High$175.77
52W Low$100.99

Repligen Corporation (RGEN) Insider Trading

Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.

SEC EDGAR · FMP · RGEN · as of Jun 8, 2026

Activity summary

Buy transactions

1

P-Purchase only

Sell transactions

22

12 Months

Buy/Sell ratio

0.05

Buy/Sell (by trades)

Overall sentiment

BEARISH
↑ Buy 4%Active transactions only · RSU vesting excluded96% Sell ↓

Repligen Corporation insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only

As of Jun 8, 2026

RGEN insider buying and selling by quarter

RGEN insider selling · RGEN insider buying stocks · quarterly insider activity

Total insider buying (incl. awards)Total insider selling
93K47K0
2025 Q3
2025 Q4
2026 Q1
2026 Q2

Mobile shows last 4Q · Desktop shows full 8Q

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters

As of Jun 8, 2026

Active insiders

Most active in past 12 months · RGEN ceo insider trading

Showing all insiders · Click a card to filter the transactions table below

Aggregated from reportingName · top 5 by trade count (12M) · no extra API

Recent insider transactions

RGEN executive sell shares · RGEN board member insider trading · RGEN insider trading SEC filing

Showing 70 most recent · Common Stock · Form 4 only

Scroll horizontally to see all columns

Madaus Martin D

Director

Award

Date

May 14

Shares

995

Price

Value

View Form 4 on SEC.gov

Konstantinov Konstantin

Director

Award

Date

May 14

Shares

995

Price

Value

View Form 4 on SEC.gov

EGLINTON MANNER CARRIE

Director

Award

Date

May 14

Shares

995

Price

Value

View Form 4 on SEC.gov

Mhatre Rohin

Director

Award

Date

May 14

Shares

995

Price

Value

View Form 4 on SEC.gov

Pax Margaret

Director

Award

Date

May 14

Shares

995

Price

Value

View Form 4 on SEC.gov

DAWES KAREN A

Director

Award

Date

May 14

Shares

995

Price

Value

View Form 4 on SEC.gov

MUIR GLENN P

Director

Award

Date

May 14

Shares

995

Price

Value

View Form 4 on SEC.gov

BARTHELEMY NICOLAS

Director

Award

Date

May 14

Shares

995

Price

Value

View Form 4 on SEC.gov

MUIR GLENN P

Director

Option

Date

May 7

Shares

2,434

Price

$38.76

Value

$94K

View Form 4 on SEC.gov

Douglass Brian Robb

CHIEF PRODUCT OFFICER

Other

Date

May 7

Shares

334

Price

$126.43

Value

$42K

View Form 4 on SEC.gov

Loeillot Olivier

CEO · Director

Sale

Date

Apr 21

Shares

3,832

Price

$140.00

Value

$536K

View Form 4 on SEC.gov

KURIYEL RALF

Senior VP, R&D

Award

Date

Mar 5

Shares

5,284

Price

Value

View Form 4 on SEC.gov

Loeillot Olivier

CEO

Award

Date

Mar 5

Shares

24,134

Price

Value

View Form 4 on SEC.gov

Bylund James

COO

Award

Date

Mar 5

Shares

7,751

Price

Value

View Form 4 on SEC.gov

Garland Jason K

CFO

Award

Date

Mar 5

Shares

7,751

Price

Value

View Form 4 on SEC.gov

Bylund James

COO

Award

Date

Mar 4

Shares

125

Price

Value

View Form 4 on SEC.gov

Bylund James

COO

Other

Date

Mar 4

Shares

62

Price

$125.84

Value

$8K

View Form 4 on SEC.gov

KURIYEL RALF

Senior VP, R&D

Award

Date

Mar 4

Shares

125

Price

Value

View Form 4 on SEC.gov

KURIYEL RALF

Senior VP, R&D

Other

Date

Mar 4

Shares

42

Price

$125.84

Value

$5K

View Form 4 on SEC.gov

Bylund James

COO

Other

Date

Feb 27

Shares

1,478

Price

$128.73

Value

$190K

View Form 4 on SEC.gov

Bylund James

COO

Other

Date

Mar 2

Shares

2,433

Price

$124.97

Value

$304K

View Form 4 on SEC.gov

Loeillot Olivier

CEO · Director

Other

Date

Feb 27

Shares

344

Price

$128.73

Value

$44K

View Form 4 on SEC.gov

Loeillot Olivier

CEO · Director

Other

Date

Mar 2

Shares

1,610

Price

$124.97

Value

$201K

View Form 4 on SEC.gov

Hunt Anthony

Director

Other

Date

Mar 2

Shares

9,897

Price

$124.97

Value

$1.24M ⚡

View Form 4 on SEC.gov

Garland Jason K

CFO

Other

Date

Feb 27

Shares

327

Price

$128.73

Value

$42K

View Form 4 on SEC.gov

⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar

1 / 3

Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —

About RGEN insider trading

RGEN insider trades

Repligen Corporation (RGEN) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Hunt Anthony (Director), Loeillot Olivier (CEO · Director), Bylund James (COO). Over the past 12 months, 5 insiders have filed transactions with the SEC. RGEN insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.

For Repligen Corporation's institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →

Buy/Sell signal logic
acquisitionOrDisposition field:
A = Acquisition (buy) · D = Disposition (sell)
RSU vesting (M-Exempt) excluded from sentiment
Form 4SEC filing required within 2 business days of any insider transaction
10b5-1Pre-scheduled trading plan that allows insiders to sell on autopilot
Open MktDirect purchase or sale on the open market (excludes awards, options)

Frequently asked questions

RGEN insider trading · 5 questions

The insiders of Repligen Corporation (RGEN) include executives and directors such as Hunt Anthony (Director), Loeillot Olivier (CEO · Director), Bylund James (COO), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.

RGEN board member insider tradingwho are RGEN insidersRGEN insider rosterRepligen Corporation executives insider activity

Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026